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 Background: Liver transplant (LT) patients have an increased risk of postoperative respiratory failure requiring tracheostomy. 
This study sought to characterize objective clinical predictors of tracheostomy.
 Material/Methods: The records for 2017 LT patients at a single institution were reviewed. Patients requiring tracheostomy were 
first compared with all other patients. A case-control subgroup analysis was conducted in which 98 tracheos-
tomy patients were matched with 98 non-tracheostomy LT patients. For the case-control study, muscle mass 
was assessed using preoperative computed tomography scans.
 Results: Among 2017 LT patients, 98 required tracheostomy (5%), with a 19% complication rate. Tracheostomy patients 
were older and had a higher model for end-stage liver disease score, a lower body mass index (BMI), and a 
greater smoking history. Tracheostomy patients had a longer hospital stay (45 vs. 10 days, P<0.001) and worse 
1-year survival (65% vs. 91%, P<0.001). Ten-year Cox regression patient survival for tracheostomy patients was 
significantly worse (32% vs. 68%, P<0.001). In the case-control analysis, respiratory failure patients were older 
(P<0.01) and had a lower BMI (P=0.05). They also had a muscle mass deficit of –39% compared with matched 
LT controls (P<0.001). No significant differences were seen with pre-LT total protein or albumin or with forced 
expiratory volume in 1 s divided by forced vital capacity (FEV1/FVC) values.
 Conclusions: Predictors for respiratory failure requiring post-LT tracheostomy include higher model for end-stage liver dis-
ease score, older age, lower BMI, greater smoking history, and worse sarcopenia. Patients requiring tracheos-
tomy have dramatically longer hospital stays and worse survival.
 MeSH Keywords: Frail Elderly • Liver Transplantation • Malnutrition • Postoperative Complications • 
Respiration, Artificial • Tracheostomy
 Abbreviations: BMI – body mass index; CT – computed tomography; FEV1 – forced expiratory volume in 1 s; 
FVC – forced vital capacity; LT – liver transplant; MRI – magnetic resonance imaging; PACS – picture ar-
chiving and communication software; PDT – percutaneous dilational tracheostomy; PFT – pulmonary 
function testing; SPSS – Statistical Package for the Social Sciences; RRS – respiratory risk score
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Background
Prolonged mechanical ventilation after liver transplant (LT) 
has been shown to be associated with increased mortality [1]. 
Previous studies have identified the incidence of posttransplant 
respiratory complications to be approximately 59–87% [2,3]. 
Many clinical factors have been found to have an impact on 
post-LT respiratory failure requiring tracheostomy including old-
er age, subjective nutritional deficiency, intraoperative bleed-
ing, pre-LT mechanical ventilation, diagnosis of acute liver fail-
ure, and re-transplantation [2,4]. Further analysis is required 
to identify additional clinical factors useful in identifying these 
high-risk patients prior to transplant.
Screening of transplant candidates prior to LT is critical to op-
timizing the utility of scarce organs. Of note, a scoring sys-
tem to calculate the risk of respiratory failure after liver trans-
plantation was recently proposed. This scoring system defines 
respiratory failure as patients requiring >7.5 days on a respi-
rator, and it takes into account many of the previously iden-
tified clinical factors to calculate risk [5]. However, preopera-
tive pulmonary function testing (PFT) and objective measures 
of wasting and frailty were not included in the scoring system.
The purpose of this study was to further identify objective clin-
ical predictors for posttransplant respiratory failure requiring 
tracheostomy. As LT patients are often deconditioned, chroni-
cally ill, and suffer from coagulopathy, this study also sought to 
better understand the impact of objective measures of pre-LT 
nutritional deficiency in patients with post-LT respiratory fail-
ure. Additionally, a thorough review of all tracheostomy pro-
cedures in these high-risk patients is reported to assess the 
incidence and types of tracheostomy-related complications.
Material and Methods
The electronic medical records of all LT recipients at a single 
center over a 16-year period were reviewed. Patients with post-
LT respiratory failure were selected based on their requirement 
for posttransplant tracheostomy. Further chart review was then 
performed for these patients to determine demographics, pre-
LT PFT results, smoking history, nutritional status, and clinical 
outcomes (hospital stay and patient survival). A case-control 
subgroup analysis was then conducted in which 98 tracheos-
tomy patients were matched with 98 non-tracheostomy LT pa-
tients based on year of transplant, model for end-stage liver 
disease score (MELD), and sex. Data collection was complete 
except for 2 patients in the respiratory failure group who did 
not have computed tomography (CT) or magnetic resonance 
imaging (MRI) scans available for review. Additionally, pre-
transplant PFT results were unavailable for 8 patients in the 
control group and 15 patients in the respiratory failure group.
Preoperative nutritional status was assessed using preopera-
tive CT scans (or MRI if CT was not available) and biochemical 
measures of serum albumin and total protein. CT measure-
ments were taken at the level of the L2/L3 intervertebral disc 
space, which has been determined to be an accurate approxi-
mation of total body composition [6]. Total psoas muscle area 
was obtained by outlining both the right and left psoas mus-
cles and summing these measurements (Figure 1). In order to 
account for variations in patient size, all measurements were 
scaled for height, as has been done previously [7]. The sar-
copenic index was obtained by dividing the total psoas area 
(cm2) by the height in meters squared. Measurements were 
taken using Synapse picture archiving and communication soft-
ware (PACS). The scaled measurements of the transplant pa-
tients were compared with the scaled measurements of MELD, 
transplant year, and sex-matched controls. The difference was 
calculated by subtracting the control measure from the trans-
plant patient measure and a percent difference was calculated.
The original operative reports for all tracheostomy procedures 
were reviewed in detail. Extracted data included ventilator days 
until tracheostomy, operating surgeon, technique, complica-
tions, days to decanulation, and risk of death with tracheos-
tomy. Any complications were described and required inter-
ventions were noted.
For this patient cohort, the posttransplant immunosuppres-
sion protocol has been described previously and includes in-
duction therapy with rabbit antithymocyte globulin and ste-
roids, followed by Prograf (tacrolimus) monotherapy [8]. Donor 
livers were recovered using standard procurement techniques 
including aortic and portal vein flushing and cold storage as 
has been described previously [9]. Ninety-five percent of all 
transplants during the study period were performed using 
Figure 1.  Cross section of patient CT scan at L2/L3 with bilateral 
psoas muscle areas highlighted.
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the piggyback hepatectomy technique, which has been de-
scribed previously and was technically equivalent for all par-
ticipating surgeons [10]. Overall median anesthesia time was 
4 h 40 min. A temporary portal-cava shunt was not created 
in any of the cases, and there was no use of veno-venous by-
pass. An antifibrinolytic agent (aprotinin, or aminocaproic acid 
or tranexamic acid) was administered routinely during the 
transplant procedure.
Standard statistical testing was utilized for continuous and 
categorical variables, as indicated. The Cox proportional haz-
ards model was constructed using a direct entry method. Co-
variates were included in the final model for P-value <0.10. 
Statistical testing was performed using the Statistical Package 
for the Social Sciences software (IBM SPSS Statistics Version 
25 [2018], IBM Corporation, Armonk, NY, USA). Retrospective 
analysis of data for LT patients at our center was reviewed 
and approved by the institutional review board of the Indiana 
University School of Medicine.
Results
Among 2017 liver transplants, 98 patients required tracheos-
tomy (5%). Tracheostomy patients had a higher MELD, older 
age, and a lower body mass index (BMI). Tracheostomy pa-
tients had a greater exposure to smoking. They did not differ 
in race or sex. Compared with the entire cohort, patients re-
quiring tracheostomy after LT had significantly longer hospi-
tal stay (45 vs. 10 days, P<0.001) and worse 1-year survival 
(65% vs. 91%, P<0.001) (Table 1).
In the case-control analysis, tracheostomy patients were older 
(P<0.01) and had a lower BMI (P=0.05). These patients also had 
a muscle mass deficit of -39% compared with matched con-
trols (P<0.001). No significant difference was found between 
groups in a comparison of biochemical markers of nutrition 
(serum total protein and albumin levels). Forced vital capaci-
ty (FVC) was found to be lower in the respiratory failure group 




1919 (95.2%) 98 (4.8%)
Recipient characteristics   
MELD (median (SD))  18 (7)  22 (9) <0.001
Gender male 67% 66% 0.88
Race
 White 89% 90% 0.38
 Black 6% 3%
 Other 5% 7%
Age in years (median (SD))  55 (10)  58 (11) 0.02
Body mass index (median (SD))  28.2 (5)  26.5 (5) <0.01
Retransplant 4% 2% 0.71
Tobacco use
 Never smoker 53% 48% 0.41
 Former smoker 47% 52%
 Current smoker at transplant 19% 17% 0.65
Pack-years smoking*
  Zero 53% 48% 0.01
 1 to 20 13% 26%
 20 to 40 25% 21%
 >40 9% 5%
Outcomes
Hospital stay (days, median (SD))  10 (31)  45 (64) <0.001
1-year survival 91% 65% <0.001
Table 1.  Demographic data for liver transplant patients who did or did not require tracheostomy for respiratory failure in the first 
6-months post transplant.
* Pack-years is the number of years of smoking multiplied by the average number of packs of cigarettes per day.
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 Number
Overall  98 (100%)
Clinical outcomes  




 Transplant surgeon  92 (94%)
 Other  6 (6%)
Days from tracheostomy to decanulation 
(median (SD))
 46 (430)
Died with tracheostomy  18 (18%)
Pulmonary function tests**
Forced vital capacity (FVC, % of predicted)  81% (20)
Forced expiratory volume in 1 second
 (FEV1,% of predicted)  76% (18)
 FEV1/FVC (% of predicted)  75% (8)
Table 2.  Subgroup analysis of 98 liver transplant patients with respiratory failure who required tracheostomy in the first 6-months 
post liver transplant.
* 2 tracheostomies were performed percutaneously; 
** 15 patients did not have PFT reports available.
 No tracheostomy (controls)  Tracheostomy (cases)  p-Value
Number 98 98
Demographics
Age (median (SD))  53 (12)  58 (11) <0.01
Model for end-stage liver disease score (SD)  22 (9)  22 (9) 0.78
Body mass index (median (SD))  27.7 (6)  26.5 (5) 0.05
Pack-years smoking (mean, median SD)  13.0 (18)  12, 3 (20) 0.82
Skeletal muscle mass**
Psoas index group median  4.6  3.2 <0.001
Psoas index matched difference  –39% (120)
Biochemical markers of nutrition
Serum albumin level (median SD)  3.0 (0.7)  2.9 (0.8) 0.97
Serum protein level (median SD)  6.5 (0.9)  6.4 (1.2) 0.97
Pulmonary function tests***
Forced vital capacity (FVC, % of predicted (SD))  88% (19)  81% (20) 0.03
Forced expiratory volume in 1 second
 (FEV1,% of predicted (SD))  83% (18)  76% (18) 0.02
FEV1/FVC (% of predicted (SD))  76% (7)  75% (8) 0.45
Clinical outcomes
Length of hospital stay (median (SD))  10 (41)  45 (64) <0.001
1-year patient survival  94%  65% <0.001
Table 3. Case control analysis of muscle mass in patients with tracheostomy and matched controls without tracheostomy*.
* Cases and controls matched for age, gender, MELD score and year of transplant; ** 2 patients in the tracheostomy group did not 




Any complication related to tracheostomy  19 (19%)
  Operative revision/post-operative 
hemorrhage
4
 Tracheocutaneous fistula/non-closure 4
 Bleeding requiring operative intervention 5
 Subcutaneous emphysema 2
 Pneumothorax/pneumomediastinum 3




Graham R.C. et al.: 
Tracheostomy after liver transplant
© Ann Transplant, 2020; 25: e920630
ORIGINAL PAPER
Indexed in: [Science Citation Index Expanded] [Index Medicus/MEDLINE] 
[Chemical Abstracts] [Scopus]
This work is licensed under Creative Common Attribution-
NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
in 1 s (FEV1) (76% vs. 83%, P=0.02). No significant difference 
between the 2 groups was noted for FEV1/FVC. Similar to the 
findings from Table 1, the case-control analysis showed an ex-
tended length of hospital stay (45 vs. 10 days, P<0.001) and 
decreased 1-year patient survival (65% vs. 94%, P<0.001) for 
the respiratory failure group (Table 2).
Subgroup analysis of the 98 tracheostomy patients was per-
formed. The median number of days between transplant and 
tracheostomy was 19 days, with a median time of 46 days from 
tracheostomy to decanulation (for survivors). Nearly all the pa-
tients failed multiple attempts at extubation prior to under-
going the tracheostomy procedure (Table 3). A transplant sur-
geon performed the tracheostomy procedure in 94% of cases. 
All but 2 tracheostomies were placed using an open technique 
in the operating room. Two tracheostomies were placed per-
cutaneously early in this series, but both required early revi-
sion due to the poor quality of the tissue. Therefore, the per-
cutaneous approach was abandoned at this center in post-LT 
patients. Pulmonary function tests among tracheostomy pa-
tients included FVC of 81% of predicted, forced expiratory vol-
ume in 1 s (FEV1) of 76% predicted, and FEV1/FVC of 75% pre-
dicted. Of the 98 tracheostomy patients, 18 (18%) died with 
their tracheostomy in place. A list of the most common com-
plications in these 98 patients is provided in Table 2. Four pa-
tients required early reoperation for dislodged tracheostomy 
or hemorrhage. Five patients had late hemorrhage requiring 
operative exploration to control bleeding. Four patients re-
quired operative closure of the tracheostomy site after devel-
oping a persistent tracheocutaneous fistula.
In a comparison of the tracheostomy group with the entire co-
hort, 10-year Cox patient survival was worse for the tracheos-
tomy patients (32% vs. 68%, P<0.001; Figure 2).
Discussion
Understanding clinical predictors of post-LT tracheostomy is es-
sential because of its association with increased costs, length-
ened hospital stay, and worse outcomes [1]. In support of pre-
vious studies, we report decreased 1- and 10-year survival 
and markedly lengthened hospital stay for post-LT tracheos-
tomy patients [1,3]. To date, there have been many identified 
risk factors for respiratory failure after LT including older age, 
subjective nutritional deficiency, intraoperative bleeding, pre-
LT mechanical ventilation, diagnosis of acute liver failure, and 
retransplantation [2,4]. However, to our knowledge, this study 
represents the first time sarcopenic index has been identified 
as a potential objective predictor of post-LT respiratory fail-
ure. The significant difference in sarcopenic index demonstrat-
ed between cohorts in the case-control portion of our analy-
sis suggests that this measurement may prove useful, without 
adding cost, to the pre-LT screening process.
Recently, a study was done to validate the use of a scoring sys-
tem to predict the risk of respiratory failure after LT. The in-
vestigators were aiming to predict the risk of post-LT 3-month 
mortality and prolonged ventilation. Their findings demonstrat-
ed that the respiratory risk score (RRS) could indeed be use-
ful to discriminate between patients with and without post-
LT respiratory failure. While the RRS includes many previously 
identified variables associated with post-LT respiratory failure, 
it does not appear to utilize any objective findings of nutrition-
al status [5]. Further, many of the included variables may not 
be available unless the patient is already in the intensive care 
unit. Calculation of the sarcopenic index requires little time 
and utilizes imaging that the patient will have already under-
gone as part of their pretransplant workup.
Although hypoalbuminemia has previously been associated 
with postoperative respiratory failure in patients receiving 
noncardiac surgery, our case-control analysis demonstrates 
that serum albumin and total protein may not be reliable clin-
ical predictors of post-LT respiratory failure [11]. This finding 
could be explained by the chronically ill state of the majority 
of LT patients. Regardless, this finding further illustrates the 
importance of identifying unique and objective signs of poor 
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Figure 2.  Cox proportional hazards patient survival post 
transplant for 98 patients with respiratory failure who 
required tracheostomy in the first 6-months post liver 
transplant (n=2017 transplants).
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that need. Both cachectic patients and patients that experience 
sarcopenic obesity may be at risk for worse outcomes. An ob-
jective measure of nutrition, such as sarcopenic index, can be 
an important clinical indicator to aid physicians in identifying 
patients at risk for perioperative and postoperative complica-
tions such as respiratory failure. There are also clinical mea-
sures of frailty such as the 6-min walk test, the 5- and 10-m 
walk tests, and grip strength testing [12,13]. With further study, 
these noninvasive measures of overall physiologic reserve may 
become important predictors for successful recovery from LT.
Pulmonary function testing is a standard portion of pre-LT eval-
uation. Unfortunately, the utility of pre-LT PFT has not been 
well documented in the literature. One recent study showed 
that patterns of restrictive lung disease were indeed associ-
ated with prolonged ventilation time after LT. The actual clin-
ical significance is uncertain, as time on the ventilator was 
increased by approximately 1 day [14]. To our knowledge, 
these are the first data to present screening PFT for LT recip-
ients who subsequently developed respiratory failure requir-
ing tracheostomy. However, it must be noted that several PFT 
reports were missing for patients in our cohort including 8 pa-
tients in the control group and 15 patients in the respirato-
ry failure group. We found that patients who experience re-
spiratory failure after LT had a lower group average FVC and 
FEV1, which suggests that worse pre-LT pulmonary function 
may be associated with post-LT respiratory failure. However, 
similar to the aforementioned study, we found FEV1/FVC was 
not significantly different for patients with post-LT respirato-
ry failure [14]. This finding could be explained by the screen-
ing of patients with extremely poor pulmonary function prior 
to LT. Further work and a larger cohort are needed to better 
understand the predictive value of pre-LT PFT for posttrans-
plant respiratory failure.
The tracheostomy procedure is generally low risk, and it is of-
ten performed at the bedside. In this series, a 19% complica-
tion rate was observed, with 4 transplant surgeons performing 
94% of the procedures. Although none of these complications 
were associated with death, many patients had to be returned 
to the operating room for bleeding or tracheostomy revision. 
The 6 other tracheostomies were placed by otolaryngology in 
patients with a known complex history of previous tracheosto-
my or neck surgery. In this series, 2 percutaneous dilational tra-
cheostomies (PDTs) were placed in post-LT patients. Both had 
significant complications requiring operative revision. In both 
cases, the patients had significant disruption (tearing) of the 
tracheal tissue, which appeared to be related to overall poor 
tissue quality. PDT requires a relatively rigid and healthy tra-
chea that can withstand the force of passing dilators of increas-
ing size through the tracheal wall. Although a small body of 
literature supports the overall safety of PDT placement in pa-
tients with liver disease, our experience is that standard tra-
cheostomy appears to be safer for the post-LT patient [15,16].
As with any retrospective study, this analysis has intrinsic 
limitations including potential documentation error and se-
lection bias. Although data from large registries have the ad-
vantage of increased statistical power, the findings from this 
single-center study offer a more granular picture. This level of 
detail is needed to appreciate and identify clinical predictors 
such as sarcopenic index, which must be computed individu-
ally for each subject. For the case-control analysis, matching 
criteria include year of transplant, sex, and MELD. Cases and 
controls were not matched by age and BMI, which both dif-
fered significantly between respiratory failure LT cases and LT 
controls and could be potential confounders. Unfortunately, 
in the matching process for this analysis, matching beyond 3 
variables became very difficult. However, the employed match-
ing criteria did provide the opportunity to identify the clinical-
ly relevant data that older patients with cachexia (i.e., elderly 
patients with lower BMI and sarcopenia) are at increased risk 
for post-LT tracheostomy.
Conclusions
The need to identify pretransplant clinical predictors of post-LT 
respiratory failure is clearly highlighted by the poor clinical out-
comes, including very poor survival, observed in patients who 
fail to wean from the ventilator. These findings suggest that 
although serum protein and albumin levels are not as useful 
in predicting post-LT clinical outcomes, sarcopenic index and 
other markers of frailty may serve as important objective mea-
surements of nutritional status in patients on the LT waiting 
list. Accurately identifying patients at high risk for poor out-
come will facilitate patient selection and improve organ utility.
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